Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 19, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Integrative oncogenomic analysis of microarray data in hematologic malignancies.

Jose A Martínez-Climent1, Lorena Fontan, Vicente Fresquet

  • 1Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.

Methods in Molecular Biology (Clifton, N.J.)
|November 3, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma.

Blood·2026
Same author

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Nature communications·2026
Same author

Cavity control of multiferroic order in single-layer NiI<sub>2</sub>.

npj computational materials·2026
Same author

PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.

Blood·2026
Same author

Multiple photon field-induced topological states in bulk HgTe.

Science advances·2026
Same author

Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation.

Briefings in bioinformatics·2026
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

DNA microarrays and integrative oncogenomics reveal human tumor genome complexity. These methods accelerate cancer gene discovery and offer future applications in clinical oncology for hematological malignancies.

Area of Science:

  • Genomics
  • Transcriptomics
  • Oncology

Background:

  • Gene expression microarrays and array-based comparative genomic hybridization (array-CGH) have significantly advanced human tumor genome analysis.
  • Integrative oncogenomic analyses combine messenger RNA (mRNA) expression and DNA copy number data for comprehensive insights.

Purpose of the Study:

  • To discuss the contributions of DNA microarrays to studying hematological malignancies.
  • To focus on integrative oncogenomic approaches correlating genomic and transcriptomic data.
  • To present the basic aspects and clinical applications of these methodologies.

Main Methods:

  • Gene expression microarrays
  • Array-based comparative genomic hybridization (array-CGH)
  • Integrative oncogenomic analyses correlating genomic and transcriptomic data

More Related Videos

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Main Results:

  • These techniques provide precise and comprehensive analysis of human tumor genomes.
  • Simultaneous assessment of mRNA expression and DNA copy number accelerates cancer gene discovery.
  • Established methodologies offer insights into hematological malignancies.

Conclusions:

  • DNA microarrays and integrative oncogenomics are powerful tools in cancer research.
  • These approaches enhance the understanding of hematological malignancies.
  • Future applications in clinical oncology are promising.